Full Title
A Phase 1b/II Study of Intratumoral CD40 Agonist 2141-V11 in Combination with Anti-PD-1 and 5-Fluorouracil Therapy in Patients with Advanced Gastroesophageal AdenocarcinomaPurpose
To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.
Contact
For more information or to see if you can join this study, please call Dr. Samuel Cytryn’s office at 646-888-4896.
Protocol
26-267
Phase
Phase I/II (phases 1 and 2 combined)
Disease Status
Newly Diagnosed & Relapsed/Refractory
Investigator
Co-Investigators
Diseases
Locations
ClinicalTrials.gov ID
NCT07818018
ClinicalTrials.gov